Limitations of a contemporary prostate biopsy: The blind march forward

Urologic Oncology: Seminars and Original Investigations

Volumn 28, Issue 5, 2010, Pages 546-549

  Wei, John T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Active surveillance; Focal therapy; Localization; Prostate biopsy; Prostate neoplasms

Indexed keywords

CRYOSURGERY; DIAGNOSTIC ACCURACY; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RELIABILITY; REVIEW; TUMOR LOCALIZATION;

BIOPSY; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 77956281194     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.12.022     Document Type: Review

References (31)

1. Siu W., Dunn R.L., Shah R.B., et al. Use of extended pattern technique for initial prostate biopsy. J Urol 2005, 174:505-509.
2. Wikipedia. Accuracy and Precision 2009.
3. Sanda M.G., Dunn R.L., Michalski J., et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. New England J Med 2008, 358:1250-1261.
4. Babaian R.J., Donnelly B., Bahn D., et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol 1993, 180:1993-2004.
5. Murat F.J., Gelet A. Current status of high-intensity focused ultrasound for prostate cancer: Technology, clinical outcomes, and future. Curr Urol Reports 2008, 9:113-121.
6. Moore C.M., Pendse D., Emberton M., et al. Photodynamic therapy for prostate cancer-a review of current status and future promise. Nature Clin Pract Urol 2009, 6:18-30.
7. Eggener S.E., Scardino P.T., Carroll P.R., et al. Focal therapy for localized prostate cancer: A critical appraisal of rationale and modalities. J Urol 2007, 178:2260-2267.
8. Schulte R.T., Wood D.P., Daignault S., et al. Utility of extended pattern prostate biopsies for tumor localization: Pathologic correlations after radical prostatectomy. Cancer 2008, 113:1559-1565.
9. Hodge K.K., McNeal J.E., Terris M.K., et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989, 142:71-74. , Discussion 74-5.
10. Babaian R.J., Toi A., Kamoi K., et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 2000, 163:152-157.
11. Borboroglu P.G., Comer S.W., Riffenburgh R.H., et al. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol 2000, 163:158-162.
12. Levine M.A., Ittman M., Melamed J., et al. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 1998, 159:471-475. , Discussion 475-6.
13. Roehl K.A., Antenor J.A., Catalona W.J. Serial biopsy results in prostate cancer screening study. J Urol 2002, 167:2435-2439.
14. Sajadi K.P., Kim T., Terris M.K., et al. High yield of saturation prostate biopsy for patients with previous negative biopsies and small prostates. Urology 2007, 70:691-695.
15. Babaian R.J., Toi A., Kamoi K., et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 2000, 163:152-157.
16. Ochiai A., Troncoso P., Babaian R.J. Comparison of cancers detected at only a sextant or alternative location. BJU Int 2008, 101:837-840.
17. Barzell W.E., Melamed M.R. Appropriate patient selection in the focal treatment of prostate cancer: The role of transperineal 3-dimensional pathologic mapping of the prostate-a 4-year experience. Urology 2007, 70(6 Suppl):27-35.
18. Onik G., Barzell W. Transperineal 3D mapping biopsy of the prostate: An essential tool in selecting patients for focal prostate cancer therapy. Urol Oncol 2008, 26:506-510.
19. Kawakami S., Hyochi N., Yonese J., et al. Three-dimensional combination of transrectal and transperineal biopsies for efficient detection of stage T1c prostate cancer. Int J Clin Oncol 2006, 11:127-132.
20. Megwalu I.I., Ferguson G.G., Wei J.T., et al. Evaluation of a novel precision template-guided biopsy system for detecting prostate cancer. BJU Int 2008, 102:546-550.
21. Lu-Yao GL, Albertsen PC, Moore DF, et al. Outcomes of localized prostate cancer following conservative management. JAMA 1202;302:1202-9.
22. Miller DC, Gruber SB, Hollenbeck BK, et al. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. J Natl Cancer Institute 1134;98:1134-41.
23. Klotz L.H. Active surveillance for good risk prostate cancer: Rationale, method, and results. Can J Urol 2005, 2:21-24.
24. Keetch D.W., Catalona W.J., Smith D.S. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 1571, 151:1571-1574.
25. Djavan B., Ravery V., Zlotta A., et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3, and 4: When should we stop. J Urol 2001, 166:1679-1683.
26. Descazeaud A., Rubin M.A., Allory Y., et al. What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer?. Eur Urol 2005, 48:911-915.
27. Kravchick S., Cytron S., Peled R., et al. Using gray-scale and two different techniques of color Doppler sonography to detect prostate cancer. Urology 2003, 61:977-981.
28. Lee B.R., Roberts W.W., Smith D.G., et al. Bioimpedance: Novel use of a minimally invasive technique for cancer localization in the intact prostate. Prostate 1999, 39:213-218.
29. Raja J., Ramachandran N., Munneke G., et al. Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer. Clin Radiol 2006, 61:142-153.
30. Ahmed H.U., Kirkham A., Arya M., et al. Is it time to consider a role for MRI before prostate biopsy?. Nat Rev Clin Oncol 2009, 6:197-206.
31. Mosquera JM, Mehra R, Regan MM, et al. Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States. Clin Cancer Res 4706;15:4706-11.